Comparison of In Vitro Approaches to Assess the Antibacterial Effects of Nanomaterials
Source abstract
Abstract
The antibacterial properties of nanomaterials (NMs) can be exploited in a range of consumer products (e.g., wound dressings, food packaging, textiles, medicines). There is also interest in the exploitation of NMs as treatments for infectious diseases to help combat antibiotic resistance. Whilst the antibacterial activity of NMs has been assessed in vitro and in vivo in numerous studies, the methodology used is very varied. Indeed, while numerous approaches are available to assess the antibacterial effect of NMs in vitro, they have not yet been systematically assessed for their suitability and sensitivity for testing NMs. It is therefore timely to consider what assays should be prioritised to screen the antibacterial properties of NMs. The majority of existing in vitro studies have focused on investigating the antibacterial effects exhibited by silver (Ag) NMs and have employed a limited range of assays. We therefore compared the antibacterial effects of copper oxide (CuO) NMs to Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Bacillus subtilis at various concentrations (12.5–200 µg/mL) using a battery of tests (well and disc diffusion, plate counts—time-kill method, optical density measurement—OD, Alamar Blue and live/dead viability assays, and quantitative polymerase chain reaction). CuO NMs were most toxic to B. subtilis and E. coli, while P. aeruginosa was the least sensitive strain. All assays employed detected the antibacterial activity of CuO NMs; however, they varied in their sensitivity, time, cost, technical difficulty and requirement for specialized equipment. In the future, we suggest that a combination of approaches is used to provide a robust assessment of the antibacterial activity of NMs. In particular, we recommend that the time-kill and OD assays are prioritised due to their greater sensitivity. We also suggest that standard operating protocols are developed so that the antibacterial activity of NMs can be assessed using a harmonised approach.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticles: synthesis and applications · Medicinal Plants and Neuroprotection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Engineering and Physical Sciences, Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh EH14 4AS, UK
Funding
European Union’s Horizon 2020 research and innovation programme · Heriot-Watt University
References (81)
Show source-provided references
1. Nanomaterials: Classification, properties, and environmental toxicities10.1016/j.eti.2020.101067 ↗
2. Toxicity of nanomaterials found in human environment: A literature review
3. Combatting antibiotic-resistant bacteria using nanomaterials10.1039/C7CS00748E ↗
4. The effects of orally administered Ag, TiO2 and SiO2 nanoparticles on gut microbiota composition and colitis induction in mice10.1016/j.impact.2017.07.005 ↗
5. Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats10.3109/17435390.2014.921346 ↗
6. Exposure of CuO nanoparticles and their metal counterpart leads to change in the gut microbiota and resistome of collembolans10.1016/j.chemosphere.2020.127347 ↗
7. Ingestion of metal-nanoparticle contaminated food disrupts endogenous microbiota in zebrafish (Danio rerio)10.1016/j.envpol.2012.11.017 ↗
8. New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials10.1016/j.taap.2015.12.017 ↗
9. Determination of Fungicidal Activities against Yeasts and Molds: Lessons Learned from Bactericidal Testing and the Need for Standardization10.1128/CMR.17.2.268-280.2004 ↗
10. Methods for in vitro evaluating antimicrobial activity: A review10.1016/j.jpha.2015.11.005 ↗
11. In vitro antibacterial and time-kill evaluation of phosphanegold(I) dithiocarbamates, R3PAu[S2CN(iPr)CH2CH2OH] for R = Ph, Cy and Et, against a broad range of Gram-positive and Gram-negative bacteria10.1007/s13404-014-0144-y ↗
12. In Vitro Bactericidal Activity of 4- and 5-Chloro-2-hydroxy-N-[1-oxo-1-(phenylamino)alkan-2-yl]benzamides against MRSA10.1155/2015/349534 ↗
13. Barry, A.L. (1999). Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline, National Committee for Clinical Laboratory Standards.
14. Characterisation of copper oxide nanoparticles for antimicrobial applications10.1016/j.ijantimicag.2008.12.004 ↗
15. Antibacterial Activity of Copper Oxide (CuO) Nanoparticles Biosynthesized by Bacillus sp. FU4: Optimization of Experiment Design10.15171/PS.2017.30 ↗
16. Effect of medium and aggregation on antibacterial activity of nanodiamonds10.1016/j.msec.2020.110930 ↗
17. In Vitro Activities of Designed Antimicrobial Peptides against Multidrug-Resistant Cystic Fibrosis Pathogens10.1128/AAC.43.6.1435 ↗
18. A comparison of conventional methods for the quantification of bacterial cells after exposure to metal oxide nanoparticles10.1186/s12866-014-0222-6 ↗
19. Elution kinetics, antimicrobial efficacy, and degradation and microvasculature of a new gentamicin-loaded collagen fleece10.1002/jbm.b.31275 ↗
20. Liakos, I.L., Grumezescu, A.M., Holban, A.M., Florin, I., D’Autilia, F., Carzino, R., Bianchini, P., and Athanassiou, A. (2016). Polylactic Acid-Lemongrass Essential Oil Nanocapsules with Antimicrobial Properties. Pharmaceuticals, 9.10.3390/ph9030042 ↗
21. Laurus nobilis leaf extract mediated green synthesis of ZnO nanoparticles: Characterization and biomedical applications10.1016/j.biopha.2016.10.038 ↗
22. Green Synthesis of Gold Nanoparticles from Vitex negundo Leaf Extract: Characterization and In Vitro Evaluation of Antioxidant–Antibacterial Activity10.1007/s10876-019-01601-z ↗
23. Facile green synthesis of silver nanoparticles from sprouted Zingiberaceae species: Spectral characterisation and its potential biological applications10.1080/10667857.2020.1863571 ↗
24. Antimicrobial effects of silver nanoparticles10.1016/j.nano.2006.12.001 ↗
25. Study on the mechanism of antibacterial action of magnesium oxide nanoparticles against foodborne pathogens10.1186/s12951-016-0202-0 ↗
26. Assessment and Interpretation of Bacterial Viability by Using the LIVE/DEAD BacLight Kit in Combination with Flow Cytometry10.1128/AEM.02750-06 ↗
27. Bankier, C., Cheong, Y., Mahalingam, S., Edirisinghe, M., Ren, G., Cloutman-Green, E., and Ciric, L. (2018). A comparison of methods to assess the antimicrobial activity of nanoparticle combinations on bacterial cells. PLoS ONE, 13.10.1371/journal.pone.0192093 ↗
28. Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni10.1128/AEM.02149-10 ↗
29. Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology10.1111/j.1574-6941.2008.00629.x ↗
30. A Basic Guide to Real Time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything10.3389/fmicb.2017.00108 ↗
31. Pop, O.L., Mesaros, A., Vodnar, D.C., Suharoschi, R., Tăbăran, F., Magerușan, L., Tódor, I.S., Diaconeasa, Z., Balint, A., and Ciontea, L. (2020). Cerium Oxide Nanoparticles and Their Efficient Antibacterial Application In Vitro against Gram-Positive and Gram-Negative Pathogens. Nanomaterials, 10.10.3390/nano10081614 ↗
32. Can disc diffusion susceptibility tests assess the antimicrobial activity of engineered nanoparticles?10.1007/s11051-018-4152-3 ↗
33. Schwalbe, R., Steele, M., and Goodwin, A.C. (2007). Antimicrobial Susceptibility Testing Protocols, CRC.10.1201/9781420014495 ↗
34. Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices10.1086/647952 ↗
35. Bioprospecting for Antibacterial Drugs: A Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls10.1007/s11095-020-02849-1 ↗
36. Karaman, D.Ş. (2017). Current Approaches for Exploration of Nanoparticles as Antibacterial Agents, IntechOpen.10.5772/68138 ↗
37. Antimicrobial applications of nanotechnology: Methods and literature
38. The importance of the viable but non-culturable state in human bacterial pathogens10.3389/fmicb.2014.00258 ↗
39. In vitro antimicrobial susceptibility testing methods: Agar dilution to 3D tissue-engineered models10.1007/s10096-017-3089-2 ↗
40. van Tonder, A., Joubert, A.M., and Cromarty, A.D. (2015). Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res. Notes, 8.10.1186/s13104-015-1000-8 ↗
41. Investigation of live and dead status of airborne bacteria using UVAPS with LIVE/DEAD® BacLight Kit10.1016/j.jaerosci.2017.10.012 ↗
42. Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci10.1128/jcm.34.2.249-253.1996 ↗
43. Does the bacterial media culture chemistry affect the stability of nanoparticles in nanotoxicity assays?10.4081/xeno.2015.5772 ↗
44. Grigore, M.E., Biscu, E.R., Holban, A.M., Gestal, M.C., and Grumezescu, A.M. (2016). Methods of Synthesis, Properties and Biomedical Applications of CuO Nanoparticles. Pharmaceuticals, 9.10.3390/ph9040075 ↗
45. Synthesis and Biomedical Applications of Copper Oxide Nanoparticles: An Expanding Horizon10.1021/acsbiomaterials.8b01092 ↗
46. Strain specificity in antimicrobial activity of silver and copper nanoparticles10.1016/j.actbio.2007.11.006 ↗
47. Understanding the Antibacterial Mechanism of CuO Nanoparticles: Revealing the Route of Induced Oxidative Stress10.1002/smll.201200772 ↗
48. Green Synthesis, Characterization and Antimicrobial Activity of Copper Oxide Nanomaterial Derived from Momordica charantia10.2147/IJN.S240232 ↗
49. Antibacterial activity of ZnO and CuO nanoparticles against gram positive and gram negative strains10.1016/j.msec.2019.109968 ↗
50. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: A comparative study10.2147/IJN.S35347 ↗
51. Size-dependent antimicrobial properties of CuO nanoparticles against Gram-positive and -negative bacterial strains10.2147/IJN.S29020 ↗
52. Cholewińska, E., Ognik, K., Fotschki, B., Zduńczyk, Z., and Juśkiewicz, J. (2018). Comparison of the effect of dietary copper nanoparticles and one copper (II) salt on the copper biodistribution and gastrointestinal and hepatic morphology and function in a rat model. PLoS ONE, 13.10.1371/journal.pone.0197083 ↗
53. Swart, E., Dvorak, J., Hernádi, S., Goodall, T., Kille, P., Spurgeon, D., Svendsen, C., and Prochazkova, P. (2020). The Effects of In Vivo Exposure to Copper Oxide Nanoparticles on the Gut Microbiome, Host Immunity, and Susceptibility to a Bacterial Infection in Earthworms. Nanomaterials, 10.10.3390/nano10071337 ↗
54. Assessment of biotoxicity of Cu nanoparticles with respect to probiotic strains of microorganisms and representatives of the normal flora of the intestine of broiler chickens10.1007/s11356-018-1761-4 ↗
55. Enhanced Antibacterial Activity of Nanocrystalline ZnO Due to Increased ROS-Mediated Cell Injury10.1002/adfm.200801081 ↗
56. A Comparative Study of Antibacterial Activity of CuO/Ag and ZnO/Ag Nanocomposites10.1155/2020/7814324 ↗
57. Enteropathogenic Escherichia coli: Unravelling pathogenesis10.1016/j.femsre.2004.07.002 ↗
58. Lung Infections Associated with Cystic Fibrosis10.1128/CMR.15.2.194-222.2002 ↗
59. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management10.1128/CMR.00134-14 ↗
60. Kimelman, H., and Shemesh, M. (2019). Probiotic Bifunctionality of Bacillus subtilis—Rescuing Lactic Acid Bacteria from Desiccation and Antagonizing Pathogenic Staphylococcus aureus. Microorganisms, 7.10.3390/microorganisms7100407 ↗
61. Bacillus cereus Group Exhibits More Resistant to Chlorhexidine Rather Than Bacillus subtilis Group10.4236/ojmm.2020.103012 ↗
62. Toxicity of copper oxide and basic copper carbonate nanoparticles after short-term oral exposure in rats10.1080/17435390.2018.1530390 ↗
63. Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure10.3109/17435390.2016.1172678 ↗
64. Ong, K.J., MacCormack, T.J., Clark, R.J., Ede, J.D., Ortega, V.A., Felix, L.C., Dang, M.K., Ma, G., Fenniri, H., and Veinot, J.G. (2014). Widespread nanoparticle-assay interference: Implications for nanotoxicity testing. PLoS ONE, 9.10.1371/journal.pone.0090650 ↗
65. Green synthesis of silver nanoparticles using Pongamia pinnata seed: Characterization, antibacterial property, and spectroscopic investigation of interaction with human serum albumin: Green synthesis of AgNP: Antibacterial activity, affinity toward HSA10.1002/jmr.2565 ↗
66. Lysates of Locusta migratoria brain exhibit potent broad-spectrum antibacterial activity10.1093/jac/dkn239 ↗
67. Optimization and validation of a PMA qPCR method for Escherichia coli quantification in primary production10.1016/j.foodcont.2015.10.014 ↗
68. Selective toxicity of ZnO nanoparticles toward Gram-positive bacteria and cancer cells by apoptosis through lipid peroxidation10.1016/j.nano.2010.10.001 ↗
69. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus
70. Interference of engineered nanoparticles with in vitro toxicity assays10.1007/s00204-012-0837-z ↗
71. Commentary: Revisiting nanoparticle-assay interference: There’s plenty of room at the bottom for misinterpretation10.1016/j.cbpb.2021.110601 ↗
72. Nanoparticles’ interference in the evaluation of in vitro toxicity of silver nanoparticles10.1039/C5RA05863E ↗
73. Interference: A Much-Neglected Aspect in High-Throughput Screening of Nanoparticles10.1177/1091581820938335 ↗
74. Detection of live Escherichia coli O157:H7 cells by PMA-qPCR
75. Nanoparticles Inhibit DNA Replication by Binding to DNA: Modeling and Experimental Validation
76. Silicon inhibition effects on the polymerase chain reaction: A real-time detection approach10.1002/jbm.a.30627 ↗
77. Growth-Based Bacterial Viability Assay for Interference-Free and High-Throughput Toxicity Screening of Nanomaterials10.1021/acs.analchem.6b04652 ↗
78. Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles10.1021/la201200r ↗
79. Difference in surface properties between Escherichia coli and Staphylococcus aureus as revealed by electrophoretic mobility measurements10.1016/0301-4622(95)00004-H ↗
80. Metal nanoparticles: Understanding the mechanisms behind antibacterial activity10.1186/s12951-017-0308-z ↗
81. Effects of Engineered Cerium Oxide Nanoparticles on Bacterial Growth and Viability10.1128/AEM.00650-10 ↗